Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a minor version update label from v3.4.1 to v3.4.2; no substantive study content or functionality changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to the study content are shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to provide additional navigation context; these are minor navigational enhancements that do not affect the study details, and To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a new Revision: v3.3.4 tag, and the old Revision: v3.3.3 tag is removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section showing Massachusetts as an enrollment site, replacing the prior Massachusetts Locations entry with a unified Locations block.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded related topics links for Prostate cancer and MedlinePlus Genetics; no changes to the main study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.